Curogen Technology Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$4.23K
- Investors
-
10
Curogen Technology General Information
Description
Operator of a biotech company intended to promote people's health. The company provides the development of rare and intractable treatments like gene therapy, protein therapy, and compound therapy based on high-efficiency molecular targeting technology, enabling healthcare providers to cure patients with new treatments and expand the horizon of medical research.
Contact Information
Website
www.curogen.co.krCorporate Office
- Medical Building Number 6309 2066 Seobu-ro
- Jangan-gu
- Suwon, Gyeonggi 02066
- South Korea
Corporate Office
- Medical Building Number 6309 2066 Seobu-ro
- Jangan-gu
- Suwon, Gyeonggi 02066
- South Korea
Curogen Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 25-Nov-2021 | $4.23K | Completed | Pre-Clinical Trials | ||
| 3. Grant | 14-Sep-2021 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A) | 26-Apr-2021 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 31-May-2019 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Curogen Technology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Curogen Technology Patents
Curogen Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4682164-A1 | Novel fusion protein for treating autoimmune diseases | Pending | 17-Mar-2023 | ||
| US-20260265340-A1 | Novel fusion protein for treating autoimmune diseases | Pending | 17-Mar-2023 | ||
| WO-2024196099-A1 | Novel fusion protein for treating autoimmune diseases | Inactive | 17-Mar-2023 | ||
| JP-2026508960-A | Novel fusion proteins for the treatment of autoimmune diseases | Pending | 17-Mar-2023 | ||
| WO-2023063804-A1 | Method for improving anti-tumor cd8+ t lymphocytes by targeting pellino1-pkcθ signaling axis | Inactive | 15-Oct-2021 |
Curogen Technology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Curogen Technology Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kingo Investment Partners | Venture Capital | Minority | ||
| Ministry of Health and Welfare (South Korea) | Government | |||
| CJ Investment | Corporate Venture Capital | Minority | ||
| GTO Investment | Venture Capital | Minority | ||
| Industrial Bank of Korea | PE/Buyout | Minority |
Curogen Technology FAQs
-
When was Curogen Technology founded?
Curogen Technology was founded in 2019.
-
Where is Curogen Technology headquartered?
Curogen Technology is headquartered in Suwon, South Korea.
-
What is the size of Curogen Technology?
Curogen Technology has 16 total employees.
-
What industry is Curogen Technology in?
Curogen Technology’s primary industry is Drug Discovery.
-
Is Curogen Technology a private or public company?
Curogen Technology is a Private company.
-
What is Curogen Technology’s current revenue?
The current revenue for Curogen Technology is .
-
Who are Curogen Technology’s investors?
Kingo Investment Partners, Ministry of Health and Welfare (South Korea), CJ Investment, GTO Investment, and Industrial Bank of Korea are 5 of 10 investors who have invested in Curogen Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
